Are you currently pregnant and have endometriosis or uterine fibroids?
If so, you may be eligible to participate in the BLOOM Pregnancy Registry. By joining this registry, you will become part of a community of women helping to advance medical knowledge. This may allow women and their doctors to make more informed decisions about their treatment options in the future. To learn more, please take a look below, and reach out if you have any questions. We would love to hear from you!
Endometriosis and pregnancy
Women may be able to take part in the BLOOM Pregnancy Registry if they:
- are pregnant and have endometriosis, and
- may or may not have taken ORILISSA® (elagolix tablets) after their last menstrual period.
Have questions? 1-(833)-782-7241
Uterine fibroids and pregnancy
Women may be able to take part in the BLOOM Pregnancy Registry if they:
- are pregnant and have uterine fibroids, and
- may or may not have taken ORIAHNN® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) after their last menstrual period.
Have questions? 1-(833)-782-7241
The BLOOM Pregnancy Registry
The BLOOM Pregnancy Registry was created to collect information about the possible effects of medications containing elagolix on pregnancy, delivery, and the health of babies. Examples of such medications are ORILISSA and ORIAHNN.
The BLOOM Pregnancy Registry is looking for the below 2 groups of participants to evaluate the pregnancy outcomes in:
- women who were taking ORILISSA or ORIAHNN during early pregnancy
- women who were not taking ORILISSA or ORIAHNN when they became pregnant, but who have endometriosis or uterine fibroids.
You DO NOT need to have taken ORILISSA or ORIAHNN to take part in this registry.
By sharing your experience, you could help doctors to better understand the possible effects of elagolix-containing medications on pregnancy, delivery, and the health of babies, to allow both doctors and women like you to make informed decisions.
Important safety information: ORILISSA and ORIAHNN should not be taken by women who are pregnant or trying to become pregnant as they may increase the risk of early pregnancy loss. Women who become pregnant while taking ORILISSA or ORIAHNN should stop taking it right away and call their healthcare provider.
